These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 12279948

  • 1. Menstrual flow duration and spotting following Multiload Copper 250 intra-uterine device insertion.
    Goh TH, Ang ES, Yip YC.
    J Obstet Gynaecol (Lahore); 1983 Oct; 4(2):127-8. PubMed ID: 12279948
    [Abstract] [Full Text] [Related]

  • 2. [[Measurement of menstrual blood loss following insertion of Copper-V 200 intrauterine device]].
    Jing PH, Huang ZL, Liu QX.
    Shengzhi Yu Biyun; 1982 Sep; 2(3):19-22. PubMed ID: 12312671
    [Abstract] [Full Text] [Related]

  • 3. [Management of abnormal bleeding in an intrauterine device user].
    Desmons F, Adam-steen C.
    Cah Sexol Clin; 1985 Sep; 11(63):185-7. PubMed ID: 12281357
    [Abstract] [Full Text] [Related]

  • 4. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA, El-genedi MM, Toppozada HK, El-abd M, Loutfi I.
    Dirasat Sukkaniyah; 1984 Sep; 11(69):27-39. PubMed ID: 12179796
    [Abstract] [Full Text] [Related]

  • 5. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
    Stanback J, Grimes D.
    Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
    [Abstract] [Full Text] [Related]

  • 6. A retrospective study of IUD usage in a Malaysian family planning clinic.
    Hamid Arshat, Jaffa Ali, Ayub Suhaimi, Yuliawiratman, Noorlaily Abu Bakar.
    Malays J Reprod Health; 1983 Dec; 1(2):191-202. PubMed ID: 12313338
    [Abstract] [Full Text] [Related]

  • 7. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
    Chen JH, Wu SC, Shao WQ, Zou MH, Hu J, Cong L, Miao L, Wang C, Dong J, Gao J, Xiao BL.
    Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
    [Abstract] [Full Text] [Related]

  • 8. [Intrauterine contraception in women over 35-years old: comparison between copper and progesterone IUDs].
    Calzolari E, Galoppi P, Masala L, Parisi C, Iannucci D, Salmaggi P, Custo GM, Zichella L.
    Patol Clin Ostet Ginecol; 1985 Jun; 13(1):49-56. PubMed ID: 12342024
    [Abstract] [Full Text] [Related]

  • 9. [Quantitative cytochemical study of ACP and AKP activity in the endometrial bleeding associated with copper intrauterine devices (IUDs)].
    Huang LL.
    Shengzhi Yu Biyun; 1991 Aug; 11(3):22-6. PubMed ID: 12343702
    [Abstract] [Full Text] [Related]

  • 10. A critical ('stress') evaluation of the combined ML Copper 250-short IUD in nulliparous women.
    Goldstuck ND.
    Contracept Deliv Syst; 1981 Oct; 2(4):287-93. PubMed ID: 12336989
    [Abstract] [Full Text] [Related]

  • 11. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J, Heikinheimo O, Lähteenmäki P, Suhonen S.
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [Abstract] [Full Text] [Related]

  • 12. [Study of IUD side-effects indicated in hysteroscopic and pathologic examinations].
    Jin EQ.
    Shengzhi Yu Biyun; 1991 Feb; 11(1):69-71. PubMed ID: 12343819
    [Abstract] [Full Text] [Related]

  • 13. Twelve-month comparative multicenter study of the TCu 380A and ML 250 intrauterine devices in Bangkok, Thailand.
    Reinprayoon D, Gilmore C, Farr G, Amatya R.
    Contraception; 1998 Oct; 58(4):201-6. PubMed ID: 9865999
    [Abstract] [Full Text] [Related]

  • 14. [Abnormal uterine bleeding in women with IUDs submitted to magnetotherapy].
    Semeraro A, De Castro G.
    Patol Clin Ostet Ginecol; 1985 Oct; 13(2):140-2. PubMed ID: 12281290
    [Abstract] [Full Text] [Related]

  • 15. [The relation between surface deposit on stainless steel IUD device and complications].
    Yuan WR.
    Shengzhi Yu Biyun; 1986 May; 6(2):41-6. PubMed ID: 12314625
    [Abstract] [Full Text] [Related]

  • 16. Control of fertility with oral medication.
    Diddle AW, Watts GF, Gardner WH, Williamson PJ.
    West J Surg Obstet Gynecol; 1964 May; 72():222-9. PubMed ID: 12305556
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of the efficacy of a venotonic capillary protector in the treatment of metrorrhagia due to IUD or micropill contraception].
    Monteil-seurin J, Bernard-fernier MF, Martinaggi P, Demarez JP, Cauquil J, Lafont A.
    Contracept Fertil Sex (Paris); 1985 May; 13(5):721-5. PubMed ID: 12267101
    [Abstract] [Full Text] [Related]

  • 18. The levonorgestrel-releasing intrauterine device.
    Toivonen J.
    Adv Contracept Deliv Syst; 1994 May; 10(3-4):191-8. PubMed ID: 12287838
    [Abstract] [Full Text] [Related]

  • 19. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
    Suvisaari J, Lähteenmäki P.
    Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
    [Abstract] [Full Text] [Related]

  • 20. Statement on intrauterine devices (IUDs).
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP.
    IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.